AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Motivating Core-muscle Exercises With Wearable Sensors, Haptics and Interactive Gaming

RecruitingNAAges 18 Years - anyAllImperial College London
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

The goal of this clinical trial is to evaluate whether a wearable biofeedback smartbelt system can improve pain and disability in adults with chronic lower back pain. The intervention combines a wearable belt that measures muscle activity with a mobile application that provides real-time feedback during exercise. The main questions it aims to answer are: * Does the MMG-biofeedback system improve disability, as measured by the Oswestry Disability Index (ODI), compared to standard care alone over an 8-week period? * Does the system reduce perceived pain levels and improve exercise adherence in individuals with lower back pain over an 8-week period? Researchers will compare participants receiving the MMG-biofeedback belt alongside standard care to those receiving standard care alone to determine whether the addition of real-time muscle activation feedback leads to improved outcomes. Par

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: 1. Over the age of 18 2. Non-specific LBP for at least 6 weeks in the past 12 months 3. Pain 4/10 on a visual analogue scale or more or Oswestry Disability Index over 20% Exclusion Criteria: 1. Serious spinal pathology ("red flags") such as: * History of malignancy with new onset back pain suggestive of recurrence. * Unexplained weight loss, fever, or systemic symptoms. * Recent significant trauma (e.g., fall from height, road traffic accident). * Suspected or confirmed spinal infection (e.g., discitis, osteomyelitis). * Cauda equina symptoms, including urinary retention/incontinence or saddle anaesthesia. * Progressive neurological deficit (e.g., worsening weakness, loss of reflexes). 2. Recent spinal surgery or invasive spinal procedures within the past 3 months. 3. Severe cardiovascular or respiratory disease that prevents safe participation in mild to moderate exercise (e.g., unstable angina, uncontrolled heart failure). 4. Pregnant women or those less than three months postpartum. 5. Known allergy to materials used in the belt (e.g., Lycra or related fabrics). 6. Cognitive impairment that prevents informed consent or ability to follow exercise instructions. 7. Concurrent participation in another intervention trial that may interfere with the study outcomes.
๐Ÿ’Š

What it tests

  • MMG-biofeedback belt
๐Ÿ“

Where

1 site
Imperial College London
London, United Kingdom
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy